Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Cross

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Emerging Microbes & Infections|June 3, 2022
Natural history of <i>Sudan ebolavirus</i> infection in rhesus and cynomolgus macaquesCourtney Woolsey, Alyssa C Fears, Viktoriya Borisevich, et al.
Scientific Reports|August 4, 2016
Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody TherapyChad E Mire, Benjamin A Satterfield, Joan B Geisbert, et al.
The Journal of Infectious Diseases|February 6, 2020
Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral ImmunityAbhishek N Prasad, Courtney Woolsey, Joan B Geisbert, et al.
The Journal of Infectious Diseases|June 22, 2023
Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant MakonaAbhishek N Prasad, Krystle N Agans, Joan B Geisbert, et al.
The Journal of Infectious Diseases|June 8, 2023
A Recombinant Vesicular Stomatitis Virus-Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus InfectionCourtney Woolsey, Jamie Strampe, Karla A Fenton, et al.
Iscience|May 25, 2026
Progression of nipah virus infection in the African green monkey: Role of macrophages and dendritic cells in early virus spreadKarla A Fenton, Jacquelyn Turcinovic, Abhishek N Prasad, et al.
NPJ Vaccines|February 9, 2021
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virusThomas W Geisbert, Kathryn Bobb, Viktoriya Borisevich, et al.
Nature Communications|July 29, 2020
Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatmentRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Viruses|May 27, 2023
A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic HenipavirusesMoushimi Amaya, Randy Yin, Lianying Yan, et al.
Plos Neglected Tropical Diseases|May 27, 2022
A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challengeCourtney Woolsey, Robert W Cross, Krystle N Agans, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Emerging Microbes & Infections|June 3, 2022
Natural history of <i>Sudan ebolavirus</i> infection in rhesus and cynomolgus macaquesCourtney Woolsey, Alyssa C Fears, Viktoriya Borisevich, et al.
Scientific Reports|August 4, 2016
Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody TherapyChad E Mire, Benjamin A Satterfield, Joan B Geisbert, et al.
The Journal of Infectious Diseases|February 6, 2020
Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral ImmunityAbhishek N Prasad, Courtney Woolsey, Joan B Geisbert, et al.
The Journal of Infectious Diseases|June 22, 2023
Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant MakonaAbhishek N Prasad, Krystle N Agans, Joan B Geisbert, et al.
The Journal of Infectious Diseases|June 8, 2023
A Recombinant Vesicular Stomatitis Virus-Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus InfectionCourtney Woolsey, Jamie Strampe, Karla A Fenton, et al.
Iscience|May 25, 2026
Progression of nipah virus infection in the African green monkey: Role of macrophages and dendritic cells in early virus spreadKarla A Fenton, Jacquelyn Turcinovic, Abhishek N Prasad, et al.
NPJ Vaccines|February 9, 2021
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virusThomas W Geisbert, Kathryn Bobb, Viktoriya Borisevich, et al.
Nature Communications|July 29, 2020
Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatmentRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Viruses|May 27, 2023
A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic HenipavirusesMoushimi Amaya, Randy Yin, Lianying Yan, et al.
Plos Neglected Tropical Diseases|May 27, 2022
A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challengeCourtney Woolsey, Robert W Cross, Krystle N Agans, et al.
Pageof 13